News

StromaCel is the fifth subsidiary of Proteonomix, whose operating subsidiary is National Stem Cell. Its subsidiary is The Sperm Bank of New York, which is engaged in reproductive

The RNA control kits, manufactured under cGMP, will enable Affymetrix to deliver a complete solution to its molecular diagnostic partners. The products will be configured for use with

EMB will acquire a license from Lonza on two key products: the Lonza Development Microreactor (process development) and Lonza Advanced Production Microreactors (manufacturing). As a result, EMB will

According to the terms of the deal, Natac, through its subsidiary Natac Research, has consented to offer the services of senior research scientists and the associated laboratory facilities,

Cilag International has given Basilea Pharmaceutica a notice of termination of the worldwide license, development and co-promotion agreement between the parties. The compound, including pending applications and in-market

GSK and makers of the other affected medicines containing LABAs have 30 days to agree with the proposed changes or state why they are not warranted. The FDA’s

Athens, Ohio-based Diagnostic Hybrids, is a manufacturer of direct fluorescent in vitro diagnostic assays used in hospital and reference laboratories for a variety of diseases, including viral respiratory

Epeius claimed that the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century, in accordance with an FDA Critical Path

Genoptix has obtained exclusive commercial laboratory rights in the US to develop and perform three solid tumor assays using HistoRx’s proprietary technology for analysis of fluorescent immunohistochemistry (fIHC),